Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Capolla

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|October 16, 2018
Complement as a Biological Tool to Control Tumor GrowthPaolo Macor, Sara Capolla, Francesco Tedesco
Cancer Medicine|February 27, 2025
CAR-T Cell Manufacturing for Hematological and Solid Tumors: From the Preclinical to Clinical Point of ViewSara Capolla, Maria Rasool, Giuseppe Toffoli, et al.
Pharmaceutics|August 28, 2021
Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal ModelSara Bozzer, Michele Dal Bo, Giuseppe Toffoli, et al.
Pharmaceutics|December 23, 2022
Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune SystemSonia Panico, Sara Capolla, Sara Bozzer, et al.
Biomedicines|September 23, 2022
Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPsSara Bozzer, Luca De Maso, Maria Cristina Grimaldi, et al.
Journal of Translational Medicine|November 29, 2023
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinomaDavide Busato, Sara Capolla, Paolo Durigutto, et al.
Nanomedicine (London, England)|May 25, 2026
PLGA/PVA nanoparticles to deliver a protein-based cancer vaccine targeting GPC1 for the treatment of pancreatic ductal adenocarcinomaMarta Gambirasi, Idris Vruzhaj, Davide Busato, et al.
International Journal of Nanomedicine|July 1, 2015
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignanciesSara Capolla, Chiara Garrovo, Sonia Zorzet, et al.
Journal of Oncology|March 19, 2020
The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic TargetLorena Baboci, Sara Capolla, Federica Di Cintio, et al.
International Journal of Pharmaceutics|December 22, 2019
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cellsBarbara Dapas, Gabriele Pozzato, Sonia Zorzet, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|October 16, 2018
Complement as a Biological Tool to Control Tumor GrowthPaolo Macor, Sara Capolla, Francesco Tedesco
Cancer Medicine|February 27, 2025
CAR-T Cell Manufacturing for Hematological and Solid Tumors: From the Preclinical to Clinical Point of ViewSara Capolla, Maria Rasool, Giuseppe Toffoli, et al.
Pharmaceutics|August 28, 2021
Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal ModelSara Bozzer, Michele Dal Bo, Giuseppe Toffoli, et al.
Pharmaceutics|December 23, 2022
Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune SystemSonia Panico, Sara Capolla, Sara Bozzer, et al.
Biomedicines|September 23, 2022
Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPsSara Bozzer, Luca De Maso, Maria Cristina Grimaldi, et al.
Journal of Translational Medicine|November 29, 2023
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinomaDavide Busato, Sara Capolla, Paolo Durigutto, et al.
Nanomedicine (London, England)|May 25, 2026
PLGA/PVA nanoparticles to deliver a protein-based cancer vaccine targeting GPC1 for the treatment of pancreatic ductal adenocarcinomaMarta Gambirasi, Idris Vruzhaj, Davide Busato, et al.
International Journal of Nanomedicine|July 1, 2015
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignanciesSara Capolla, Chiara Garrovo, Sonia Zorzet, et al.
Journal of Oncology|March 19, 2020
The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic TargetLorena Baboci, Sara Capolla, Federica Di Cintio, et al.
International Journal of Pharmaceutics|December 22, 2019
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cellsBarbara Dapas, Gabriele Pozzato, Sonia Zorzet, et al.
Pageof 2